Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2010
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors
Kyoichi Kaira, Masahiro Endo, Masato Abe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2016
Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study
Tomoya Kawaguchi, Yasuhiro Koh, Masahiko Ando, et al.
Journal of Pain and Symptom Management
|
November 22, 2023
A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients
Eri Takase, Hiroaki Akamatsu, Shunsuke Teraoka, et al.
Plos One
|
July 11, 2013
Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system
Masahito Hosokawa, Hirotsugu Kenmotsu, Yasuhiro Koh, et al.
Cancer Science
|
October 21, 2020
CD24, not CD47, negatively impacts upon response to PD-1/L1 inhibitors in non-small-cell lung cancer with PD-L1 tumor proportion score < 50
Yuichi Ozawa, Yuhei Harutani, Jun Oyanagi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2019
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site
Hidetoshi Hayashi, Takayasu Kurata, Yuichi Takiguchi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 21, 2024
Comprehensive serum biomarker analysis reveals IL-8 changes as the only predictor of the effectiveness of immune checkpoint inhibitors for patients with advanced non-small cell lung cancer
Hiroaki Akamatsu, Yasuhiro Koh, Makoto Nishio, et al.
Plos One
|
May 15, 2013
A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer
Issei Kurahashi, Yoshihiko Fujita, Tokuzo Arao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 19, 2025
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET)
Hiroaki Akamatsu, Shinya Sakata, Koichi Azuma, et al.
Biomedical Reports
|
October 1, 2019
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing
Satoshi Fujii, Takayuki Yoshino, Kentaro Yamazaki, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2010
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors
Kyoichi Kaira, Masahiro Endo, Masato Abe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2016
Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study
Tomoya Kawaguchi, Yasuhiro Koh, Masahiko Ando, et al.
Journal of Pain and Symptom Management
|
November 22, 2023
A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients
Eri Takase, Hiroaki Akamatsu, Shunsuke Teraoka, et al.
Plos One
|
July 11, 2013
Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system
Masahito Hosokawa, Hirotsugu Kenmotsu, Yasuhiro Koh, et al.
Cancer Science
|
October 21, 2020
CD24, not CD47, negatively impacts upon response to PD-1/L1 inhibitors in non-small-cell lung cancer with PD-L1 tumor proportion score < 50
Yuichi Ozawa, Yuhei Harutani, Jun Oyanagi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2019
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site
Hidetoshi Hayashi, Takayasu Kurata, Yuichi Takiguchi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 21, 2024
Comprehensive serum biomarker analysis reveals IL-8 changes as the only predictor of the effectiveness of immune checkpoint inhibitors for patients with advanced non-small cell lung cancer
Hiroaki Akamatsu, Yasuhiro Koh, Makoto Nishio, et al.
Plos One
|
May 15, 2013
A microarray-based gene expression analysis to identify diagnostic biomarkers for unknown primary cancer
Issei Kurahashi, Yoshihiko Fujita, Tokuzo Arao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 19, 2025
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET)
Hiroaki Akamatsu, Shinya Sakata, Koichi Azuma, et al.
Biomedical Reports
|
October 1, 2019
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing
Satoshi Fujii, Takayuki Yoshino, Kentaro Yamazaki, et al.
Page
of 15